PIWIL4 has been detected at elevated levels in MDA-MB-231 cells, a breast cancer cell line [53], and PIWIL2 has been proposed as a promising biomarker for breast cancer, being expressed across various disease stages and present in all examined tissue microarray cores [54]. This evidence concerns the gene PIWIL4 and breast carcinoma.